AU3977699A - Ags proteins and nucleic acid molecules and uses therefor - Google Patents

Ags proteins and nucleic acid molecules and uses therefor

Info

Publication number
AU3977699A
AU3977699A AU39776/99A AU3977699A AU3977699A AU 3977699 A AU3977699 A AU 3977699A AU 39776/99 A AU39776/99 A AU 39776/99A AU 3977699 A AU3977699 A AU 3977699A AU 3977699 A AU3977699 A AU 3977699A
Authority
AU
Australia
Prior art keywords
nucleic acid
acid molecules
uses therefor
ags proteins
ags
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU39776/99A
Inventor
Mary Cismowski
Emir Duzic
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cadus Pharmaceutical Corp
Original Assignee
Cadus Pharmaceutical Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cadus Pharmaceutical Corp filed Critical Cadus Pharmaceutical Corp
Publication of AU3977699A publication Critical patent/AU3977699A/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G01N33/5041—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects involving analysis of members of signalling pathways
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4705—Regulators; Modulating activity stimulating, promoting or activating activity
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5011—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing antineoplastic activity
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/37—Assays involving biological materials from specific organisms or of a specific nature from fungi
    • G01N2333/39—Assays involving biological materials from specific organisms or of a specific nature from fungi from yeasts
    • G01N2333/395—Assays involving biological materials from specific organisms or of a specific nature from fungi from yeasts from Saccharomyces

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Chemistry (AREA)
  • Toxicology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
AU39776/99A 1998-05-08 1999-05-07 Ags proteins and nucleic acid molecules and uses therefor Abandoned AU3977699A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US8484298P 1998-05-08 1998-05-08
US60084842 1998-05-08
US10335598P 1998-10-07 1998-10-07
US60103355 1998-10-07
PCT/US1999/010151 WO1999058670A1 (en) 1998-05-08 1999-05-07 Ags proteins and nucleic acid molecules and uses therefor

Publications (1)

Publication Number Publication Date
AU3977699A true AU3977699A (en) 1999-11-29

Family

ID=26771493

Family Applications (1)

Application Number Title Priority Date Filing Date
AU39776/99A Abandoned AU3977699A (en) 1998-05-08 1999-05-07 Ags proteins and nucleic acid molecules and uses therefor

Country Status (2)

Country Link
AU (1) AU3977699A (en)
WO (1) WO1999058670A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000068249A2 (en) * 1999-05-07 2000-11-16 Musc Foundation For Research Development Novel g-protein modulator (gpm) proteins and nucleic acid molecules and uses therefor
US7590493B2 (en) 2000-07-31 2009-09-15 Ocimum Biosolutions, Inc. Methods for determining hepatotoxins
AU2001295955A1 (en) * 2000-10-19 2002-04-29 Takeda Chemical Industries Ltd. Novel disease-associated gene and use thereof
EP1339740A2 (en) * 2000-12-01 2003-09-03 Wyeth Methods and cells for detecting modulators of rgs proteins
US6969588B2 (en) * 2001-02-08 2005-11-29 Applera Corporation Isolated human ras-like proteins, nucleic acid molecules encoding these human ras-like proteins, and uses thereof
EP1392871A4 (en) 2001-05-22 2006-04-19 Gene Logic Inc Molecular toxicology modeling
US7447594B2 (en) 2001-07-10 2008-11-04 Ocimum Biosolutions, Inc. Molecular cardiotoxicology modeling
GB2549798A (en) * 2016-04-29 2017-11-01 Univ Bradford Peptides and nanoparticle formulations thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU5748694A (en) * 1992-12-10 1994-07-04 Beth Israel Hospital Association, The D4 gene and methods of use thereof
WO1994023025A1 (en) * 1993-03-31 1994-10-13 Cadus Pharmaceuticals, Inc. Yeast cells engineered to produce pheromone system protein surrogates, and uses therefor
AU9791198A (en) * 1997-10-07 1999-04-27 Cadus Pharmaceutical Corporation Yeast cells expressing modified g proteins and methods of use therefor

Also Published As

Publication number Publication date
WO1999058670A1 (en) 1999-11-18

Similar Documents

Publication Publication Date Title
AU4567499A (en) Novel mtbx protein and nucleic acid molecules and uses therefor
AU6029998A (en) Dna molecules and protein displaying improved triazine compound degrading ability
IL135823A0 (en) Isolated nucleic acid molecule encoding mammalian endoglucuronidase and uses therefor
AU3510200A (en) Human dickkopf-related protein and nucleic acid molecules and uses therefor
AU5587799A (en) Protein transport-associated molecules
AU1934899A (en) Toxoplasma gondii proteins, corresponding nucleic acid molecules, and uses thereof
AU3354499A (en) Human mekk proteins, corresponding nucleic acid molecules, and uses therefor
EP1001964A4 (en) Tango-78, tango-79, and tango-81 nucleic acid molecules and polypeptides
EP1051427A4 (en) Spoil protein and nucleic acid molecules and uses therefor
AU5901199A (en) Novel irap-bp polypeptide and nucleic acid molecules and uses therefor
IL138216A0 (en) Novel fdrg protein and nucleic acid molecules and uses therefor
AU3977699A (en) Ags proteins and nucleic acid molecules and uses therefor
AU2002243750A1 (en) Novel nucleic acid and polypeptide molecules
EP1071749A4 (en) Novel lrsg protein and nucleic acid molecules and uses therefor
EP1109824A4 (en) Novel bag proteins and nucleic acid molecules encoding them
AU2001249929A1 (en) Fdrg proteins and nucleic acid molecules and uses therefor
AU1137699A (en) Novel reovirus-derived proteins, nucleic acids encoding same, and uses therefor
AU5312699A (en) Novel mp-7 protein and nucleic acid molecules and uses therefor
AU4826899A (en) Novel msp-5 protein and nucleic acid molecules and uses therefor
AU2801597A (en) Flea protease proteins, nucleic acid molecules, and uses thereof
AU6410599A (en) Novel protein phosphatase molecules and uses therefor
EP1066310A4 (en) Neokine protein and nucleic acid molecules and uses therefor
AU2002323612A1 (en) Novel clark protein and nucleic acid molecules and uses therefor
AU2001259240A1 (en) Novel stmst protein and nucleic acid mocecules and uses therefor
EP1007682A4 (en) Novel nucleic acid molecules and uses therefor

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase